Literature DB >> 22835215

Fulfilling the metabolic requirements for cell proliferation.

Salvador Moncada1, E Annie Higgs, Sergio L Colombo.   

Abstract

The activity of key metabolic enzymes is regulated by the ubiquitin ligases that control the function of the cyclins; therefore the activity of these ubiquitin ligases explains the coordination of cell-cycle progression with the supply of substrates necessary for cell duplication. APC/C (anaphase-promoting complex/cyclosome)-Cdh1, the ubiquitin ligase that controls G(1)- to S-phase transition by targeting specific degradation motifs in cell-cycle proteins, also regulates the glycolysis-promoting enzyme PFKFB3 (6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase isoform 3) and GLS1 (glutaminase 1), a critical enzyme in glutaminolysis. A decrease in the activity of APC/C-Cdh1 in mid-to-late G(1) releases both proteins, thus explaining the simultaneous increase in the utilization of glucose and glutamine during cell proliferation. This occurs at a time consistent with the point in G(1) that has been described as the nutrient-sensitive restriction point and is responsible for the transition from G(1) to S. PFKFB3 is also a substrate at the onset of S-phase for the ubiquitin ligase SCF (Skp1/cullin/F-box)-β-TrCP (β-transducin repeat-containing protein), so that the activity of PFKFB3 is short-lasting, coinciding with a peak in glycolysis in mid-to-late G(1), whereas the activity of GLS1 remains high throughout S-phase. The differential regulation of the activity of these proteins indicates that a finely-tuned set of mechanisms is activated to fulfil specific metabolic demands at different stages of the cell cycle. These findings have implications for the understanding of cell proliferation in general and, in particular, of cancer, its prevention and treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22835215     DOI: 10.1042/BJ20120427

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  37 in total

Review 1.  Changing appetites: the adaptive advantages of fuel choice.

Authors:  Illana A Stanley; Sofia M Ribeiro; Alfredo Giménez-Cassina; Erik Norberg; Nika N Danial
Journal:  Trends Cell Biol       Date:  2013-09-07       Impact factor: 20.808

2.  Quercetin modulates keratoconus metabolism in vitro.

Authors:  Tina B McKay; Akhee Sarker-Nag; Desiree' Lyon; John M Asara; Dimitrios Karamichos
Journal:  Cell Biochem Funct       Date:  2015-07-14       Impact factor: 3.685

Review 3.  Glucose and glutamine metabolism control by APC and SCF during the G1-to-S phase transition of the cell cycle.

Authors:  Irving Omar Estévez-García; Verónica Cordoba-Gonzalez; Eleazar Lara-Padilla; Abel Fuentes-Toledo; Ramcés Falfán-Valencia; Rafael Campos-Rodríguez; Edgar Abarca-Rojano
Journal:  J Physiol Biochem       Date:  2014-03-07       Impact factor: 4.158

4.  Reciprocal regulation of acetyl-CoA carboxylase 1 and senescence in human fibroblasts involves oxidant mediated p38 MAPK activation.

Authors:  Inés Marmisolle; Jennyfer Martínez; Jie Liu; Mauricio Mastrogiovanni; María M Fergusson; Ilsa I Rovira; Laura Castro; Andrés Trostchansky; María Moreno; Liu Cao; Toren Finkel; Celia Quijano
Journal:  Arch Biochem Biophys       Date:  2016-10-27       Impact factor: 4.013

5.  Dual inhibition of glutaminase and carnitine palmitoyltransferase decreases growth and migration of glutaminase inhibition-resistant triple-negative breast cancer cells.

Authors:  Larissa Menezes Dos Reis; Douglas Adamoski; Rodolpho Ornitz Oliveira Souza; Carolline Fernanda Rodrigues Ascenção; Krishina Ratna Sousa de Oliveira; Felipe Corrêa-da-Silva; Fábio Malta de Sá Patroni; Marília Meira Dias; Sílvio Roberto Consonni; Pedro Manoel Mendes de Moraes-Vieira; Ariel Mariano Silber; Sandra Martha Gomes Dias
Journal:  J Biol Chem       Date:  2019-04-30       Impact factor: 5.157

6.  Glutaminase inhibitor compound 968 inhibits cell proliferation and sensitizes paclitaxel in ovarian cancer.

Authors:  Lingqin Yuan; Xiugui Sheng; Leslie H Clark; Lu Zhang; Hui Guo; Hannah M Jones; Adam K Willson; Paola A Gehrig; Chunxiao Zhou; Victoria L Bae-Jump
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

7.  Feasibility and antitumor efficacy in vivo, of simultaneously targeting glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6-diazo-5-oxo-L-norleucine and orlistat in colon cancer.

Authors:  Diana Cervantes-Madrid; Guadalupe Dominguez-Gomez; Aurora Gonzalez-Fierro; Enrique Perez-Cardenas; Lucia Taja-Chayeb; Catalina Trejo-Becerril; Alfonso Duenas-Gonzalez
Journal:  Oncol Lett       Date:  2017-01-18       Impact factor: 2.967

Review 8.  MYC, Metabolism, and Cancer.

Authors:  Zachary E Stine; Zandra E Walton; Brian J Altman; Annie L Hsieh; Chi V Dang
Journal:  Cancer Discov       Date:  2015-09-17       Impact factor: 39.397

Review 9.  Glutaminolysis as a target for cancer therapy.

Authors:  L Jin; G N Alesi; S Kang
Journal:  Oncogene       Date:  2015-11-23       Impact factor: 9.867

10.  Metabolomic studies identify changes in transmethylation and polyamine metabolism in a brain-specific mouse model of tuberous sclerosis complex.

Authors:  James McKenna; David Kapfhamer; Jason M Kinchen; Brandi Wasek; Matthew Dunworth; Tracy Murray-Stewart; Teodoro Bottiglieri; Robert A Casero; Michael J Gambello
Journal:  Hum Mol Genet       Date:  2018-06-15       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.